RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/a-2075-1198
Long-term follow-up after transoral outlet reduction following Roux-en-Y gastric bypass: Back to stage 0?
Authors
TRIAL REGISTRATION: Extended follow-up study for a RCT NCT03094936 at ClinicalTrials.gov
Abstract
Background and study aims Significant weight regain affects up to one-third of patients after Roux-en-Y gastric bypass (RYGB) and demands treatment. Transoral outlet reduction (TORe) with argon plasma coagulation (APC) alone or APC plus full-thickness suturing TORe (APC-FTS) is effective in the short term. However, no study has investigated the course of gastrojejunostomy (GJ) or quality of life (QOL) data after the first post-procedure year.
Patients and methods Patients eligible for a 36-month follow-up visit after TORe underwent upper gastrointestinal endoscopy with measurement of the GJ and answered QOL questionnaires (RAND-36). The primary aim was to evaluate the long-term outcomes of TORe, including weight loss, QOL, and GJ anastomosis (GJA) size. Comparisons between APC and APC-FTS TORe were a secondary aim.
Results Among 39 eligible patients, 29 returned for the 3-year follow-up visit. There were no significant differences in demographics between APC and APC-FTS TORe groups. At 3 years, patients from both groups regained all the weight lost at 12 months, and the GJ diameter was similar to the pre-procedure assessment. As to QOL, most improvements seen at 12 months were lost at 3 years, returning to pre-procedure levels. Only the energy/fatigue domain improvement was kept between the 1- and 3-year visits.
Conclusions Obesity is a chronic relapsing disease. Most effects of TORe are lost at 3 years, and redilation of the GJA occurs. Therefore, TORe should be considered iterative rather than a one-off procedure.
Publikationsverlauf
Eingereicht: 17. Februar 2023
Angenommen nach Revision: 14. April 2023
Accepted Manuscript online:
17. April 2023
Artikel online veröffentlicht:
26. Mai 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Carlsson LMS, Sjöholm K, Jacobson P. et al. Life expectancy after bariatric surgery in the Swedish Obese Subjects Study. N Engl J Med 2020; 383: 1535-1543
- 2
Eisenberg D,
Shikora SA,
Aarts E.
et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International
Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications
for metabolic and bariatric surgery. Surg Obes Relat Dis 2022; 18: 1345-1356
Reference Ris Wihthout Link
- 3 Angrisani L, Santonicola A, Iovino P. et al. Bariatric surgery survey 2018: Similarities and disparities among the 5 IFSO chapters. Obes Surg 2021; 31: 1937-1948
- 4 Cooper TC, Simmons EB, Webb K. et al. Trends in weight regain following Roux-en-Y gastric bypass (RYGB) bariatric surgery. Obes Surg 2015; 25: 1474-1481
- 5 Jirapinyo P, Abu Dayyeh BK, Thompson CC. Weight regain after Roux-en-Y gastric bypass has a large negative impact on the Bariatric Quality of Life Index. BMJ Open Gastroenterol 2017; 4: e000153-e000153
- 6 Kuzminov A, Palmer AJ, Wilkinson S. et al. Re-operations after secondary bariatric surgery: a systematic review. Obes Surg 2016; 26: 2237-2247
- 7 Brunaldi VO, Farias GFA, de Rezende DT. et al. Argon plasma coagulation alone versus argon plasma coagulation plus full-thickness endoscopic suturing to treat weight regain after Roux-en-Y gastric bypass: a prospective randomized trial (with videos). Gastrointest Endosc 2020; 92: 97-107.e105
- 8 Jaruvongvanich V, Vantanasiri K, Laoveeravat P. et al. Endoscopic full-thickness suturing plus argon plasma mucosal coagulation versus argon plasma mucosal coagulation alone for weight regain after gastric bypass: a systematic review and meta-analysis. Gastrointest Endosc 2020; 92: 1164-1175.e1166
- 9 Moon RC, Teixeira AF, Neto MG. et al. Efficacy of utilizing argon plasma coagulation for weight regain in Roux-en-Y gastric bypass patients: a multi-center study. Obesity Surg 2018; 28: 2737-2744
- 10 Brunaldi VO, Jirapinyo P, de Moura DTH. et al. Endoscopic treatment of weight regain following Roux-en-Y gastric bypass: a systematic review and meta-analysis. Obes Surg 2018; 28: 266-276
- 11 Jirapinyo P, Kumar N, AlSamman MA. et al. Five-year outcomes of transoral outlet reduction for the treatment of weight regain after Roux-en-Y gastric bypass. Gastrointest Endosc 2020; 91: 1067-1073
- 12 Callahan ZM, Su B, Kuchta K. et al. Five-year results of endoscopic gastrojejunostomy revision (transoral outlet reduction) for weight gain after gastric bypass. Surg Endosc 2019; 34: 2164-2171
- 13 Baretta GAP, Alhinho HCAW, Matias JEF. et al. Argon plasma coagulation of gastrojejunal anastomosis for weight regain after gastric bypass. Obes Surg 2015; 25: 72-79
- 14 Galvao Neto M, Brunaldi VO, Grecco E. et al. Good clinical practices on argon plasma coagulation treatment for weight regain associated with dilated gastrojejunostomy following Roux-en-Y gastric bypass: a Brazilian-modified delphi consensus. Obes Surg 2022; 32: 273-283
- 15 Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health economics 1993; 2: 217-227
- 16 Kumar N, Thompson CC. Transoral outlet reduction for weight regain after gastric bypass: long-term follow-up. Gastrointest Endosc 2016; 83: 776-779
- 17 Zeigler Z. COVID-19 self-quarantine and weight gain risk factors in adults. Curr Obes Rep 2021; 10: 423-433
- 18 Chang TH, Chen YC, Chen WY. et al. Weight gain associated with COVID-19 lockdown in children and adolescents: a systematic review and meta-analysis. Nutrients 2021; 13: 3668
- 19 Yanos BR, Saules KK, Schuh LM. et al. Predictors of lowest weight and long-term weight regain among Roux-en-Y gastric bypass patients. Obes Surg 2015; 25: 1364-1370
- 20 Bauraitė K, Mikuckytė D, Gudaitytė R. et al. Factors associated with quality of life and weight regain 12 years after Roux-en-Y gastric bypass. Surg Endosc 2022; 36: 4333-4341
- 21 Smith C, Garren M, Gould J. Impact of gastrojejunostomy diameter on long-term weight loss following laparoscopic gastric bypass: a follow-up study. Surg Endosc 2011; 25: 2164-2167
- 22 Sampaio-Neto J, Branco-Filho AJ, Nassif LS. et al. Complications related to gastric bypass performed with different gastrojejunal diameters. Arq Bras Cir Dig 2016; 29: 12-14
- 23 Abu Dayyeh BK, Lautz DB, Thompson CC. Gastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass. Clin Gastroenterol Hep 2011; 9: 228-233
- 24 Abu Dayyeh BK, Jirapinyo P, Thompson CC. Plasma ghrelin levels and weight regain after Roux-en-Y gastric bypass surgery. Obes Surg 2017; 27: 1031-1036
- 25 Cambi MPC, Baretta GAP, Magro DO. et al. Multidisciplinary approach for weight regain-how to manage this challenging condition: an expert review. Obes Surg 2021; 31: 1290-1303